Dare Non Current Assets Total vs Total Stockholder Equity Analysis

DARE Stock

USD 2.99 0.01 0.33%

Dare Bioscience financial indicator trend analysis is much more than just examining Dare Bioscience latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dare Bioscience is a good investment. Please check the relationship between Dare Bioscience Non Current Assets Total and its Total Stockholder Equity accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dare Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.

Non Current Assets Total vs Total Stockholder Equity

Non Current Assets Total vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dare Bioscience Non Current Assets Total account and Total Stockholder Equity. At this time, the significance of the direction appears to have pay attention.

The correlation between Dare Bioscience's Non Current Assets Total and Total Stockholder Equity is -1.0. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Dare Bioscience, assuming nothing else is changed. The correlation between historical values of Dare Bioscience's Non Current Assets Total and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Dare Bioscience are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Non Current Assets Total i.e., Dare Bioscience's Non Current Assets Total and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-1.0

Relationship Direction	Negative
Relationship Strength	Strong

View All Relationships

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from Dare Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dare Bioscience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dare Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.At present, Dare Bioscience's Sales General And Administrative To Revenue is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 1.4 B, whereas Enterprise Value Over EBITDA is projected to grow to (53.32).

Dare Bioscience fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Property Plant And Equipment Gross	Common Stock Total Equity	Other Liab	Net Tangible Assets
Total Assets		1.0	1.0	1.0	-1.0	1.0	0.1	-1.0	0.06	-0.1	1.0	1.0	1.0	-0.36	0.69	1.0	1.0	1.0	1.0	1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Short Long Term Debt Total	1.0		1.0	1.0	-1.0	1.0	0.09	-1.0	0.06	-0.1	1.0	1.0	1.0	-0.35	0.69	1.0	1.0	1.0	1.0	1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Other Current Liab	1.0	1.0		1.0	-1.0	1.0	0.1	-1.0	0.06	-0.11	1.0	1.0	1.0	-0.36	0.69	1.0	1.0	1.0	1.0	1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Total Current Liabilities	1.0	1.0	1.0		-1.0	1.0	0.1	-1.0	0.06	-0.11	1.0	1.0	1.0	-0.36	0.69	1.0	1.0	1.0	1.0	1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Total Stockholder Equity	-1.0	-1.0	-1.0	-1.0		-1.0	-0.11	1.0	-0.05	0.12	-1.0	-1.0	-1.0	0.36	-0.69	-1.0	-1.0	-1.0	-1.0	-1.0	0.27	-0.46	-0.87	-0.55	-0.28	0.15
Property Plant And Equipment Net	1.0	1.0	1.0	1.0	-1.0		0.1	-1.0	0.06	-0.11	1.0	1.0	1.0	-0.36	0.69	1.0	1.0	1.0	1.0	1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Net Debt	0.1	0.09	0.1	0.1	-0.11	0.1		-0.1	-0.44	-0.97	0.1	0.1	0.1	-0.66	-0.15	0.1	0.1	0.1	0.1	0.09	-0.36	-0.21	0.08	-0.29	-0.13	-0.47
Retained Earnings	-1.0	-1.0	-1.0	-1.0	1.0	-1.0	-0.1		-0.06	0.11	-1.0	-1.0	-1.0	0.36	-0.69	-1.0	-1.0	-1.0	-1.0	-1.0	0.27	-0.46	-0.87	-0.56	-0.29	0.15
Accounts Payable	0.06	0.06	0.06	0.06	-0.05	0.06	-0.44	-0.06		0.44	0.06	0.06	0.06	0.49	0.63	0.06	0.06	0.06	0.06	0.06	0.8	0.63	0.45	0.66	0.57	0.23
Cash	-0.1	-0.1	-0.11	-0.11	0.12	-0.11	-0.97	0.11	0.44		-0.11	-0.11	-0.1	0.69	0.09	-0.11	-0.1	-0.11	-0.1	-0.1	0.28	0.11	-0.07	0.26	0.11	0.5
Non Current Assets Total	1.0	1.0	1.0	1.0	-1.0	1.0	0.1	-1.0	0.06	-0.11		1.0	1.0	-0.36	0.69	1.0	1.0	1.0	1.0	1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Non Currrent Assets Other	1.0	1.0	1.0	1.0	-1.0	1.0	0.1	-1.0	0.06	-0.11	1.0		1.0	-0.36	0.69	1.0	1.0	1.0	1.0	1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Cash And Short Term Investments	1.0	1.0	1.0	1.0	-1.0	1.0	0.1	-1.0	0.06	-0.1	1.0	1.0		-0.36	0.69	1.0	1.0	1.0	1.0	1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Net Receivables	-0.36	-0.35	-0.36	-0.36	0.36	-0.36	-0.66	0.36	0.49	0.69	-0.36	-0.36	-0.36		0.04	-0.36	-0.36	-0.36	-0.36	-0.35	0.51	0.2	-0.18	0.24	0.32	0.27
Common Stock Shares Outstanding	0.69	0.69	0.69	0.69	-0.69	0.69	-0.15	-0.69	0.63	0.09	0.69	0.69	0.69	0.04		0.69	0.69	0.69	0.69	0.69	0.47	0.87	0.79	0.87	0.59	-0.1
Non Current Liabilities Total	1.0	1.0	1.0	1.0	-1.0	1.0	0.1	-1.0	0.06	-0.11	1.0	1.0	1.0	-0.36	0.69		1.0	1.0	1.0	1.0	-0.27	0.45	0.87	0.56	0.27	-0.15
Other Stockholder Equity	1.0	1.0	1.0	1.0	-1.0	1.0	0.1	-1.0	0.06	-0.1	1.0	1.0	1.0	-0.36	0.69	1.0		1.0	1.0	1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Total Liab	1.0	1.0	1.0	1.0	-1.0	1.0	0.1	-1.0	0.06	-0.11	1.0	1.0	1.0	-0.36	0.69	1.0	1.0		1.0	1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Total Current Assets	1.0	1.0	1.0	1.0	-1.0	1.0	0.1	-1.0	0.06	-0.1	1.0	1.0	1.0	-0.36	0.69	1.0	1.0	1.0		1.0	-0.27	0.45	0.87	0.56	0.28	-0.15
Short Term Debt	1.0	1.0	1.0	1.0	-1.0	1.0	0.09	-1.0	0.06	-0.1	1.0	1.0	1.0	-0.35	0.69	1.0	1.0	1.0	1.0		-0.27	0.45	0.87	0.56	0.28	-0.15
Common Stock	-0.27	-0.27	-0.27	-0.27	0.27	-0.27	-0.36	0.27	0.8	0.28	-0.27	-0.27	-0.27	0.51	0.47	-0.27	-0.27	-0.27	-0.27	-0.27		0.6	0.04	0.56	0.58	0.0
Current Deferred Revenue	0.45	0.45	0.45	0.45	-0.46	0.45	-0.21	-0.46	0.63	0.11	0.45	0.45	0.45	0.2	0.87	0.45	0.45	0.45	0.45	0.45	0.6		0.6	0.7	0.55	0.05
Property Plant And Equipment Gross	0.87	0.87	0.87	0.87	-0.87	0.87	0.08	-0.87	0.45	-0.07	0.87	0.87	0.87	-0.18	0.79	0.87	0.87	0.87	0.87	0.87	0.04	0.6		0.65	0.42	-0.07
Common Stock Total Equity	0.56	0.56	0.56	0.56	-0.55	0.56	-0.29	-0.56	0.66	0.26	0.56	0.56	0.56	0.24	0.87	0.56	0.56	0.56	0.56	0.56	0.56	0.7	0.65		0.83	-0.24
Other Liab	0.28	0.28	0.28	0.28	-0.28	0.28	-0.13	-0.29	0.57	0.11	0.28	0.28	0.28	0.32	0.59	0.27	0.28	0.28	0.28	0.28	0.58	0.55	0.42	0.83		-0.45
Net Tangible Assets	-0.15	-0.15	-0.15	-0.15	0.15	-0.15	-0.47	0.15	0.23	0.5	-0.15	-0.15	-0.15	0.27	-0.1	-0.15	-0.15	-0.15	-0.15	-0.15	0.0	0.05	-0.07	-0.24	-0.45

Click cells to compare fundamentals

Dare Bioscience Account Relationship Matchups

Dare Bioscience fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	7.6M	55.8M	43.8M	21.3M	22.1B	23.2B
Short Long Term Debt Total	756.8K	270.5K	488.7K	1.4M	1.3B	1.4B
Other Current Liab	4.4M	3.1M	10.9M	2.9M	21.0B	22.1B
Total Current Liabilities	7.7M	16.1M	31.6M	20.5M	21.6B	22.7B
Total Stockholder Equity	(1.2M)	38.8M	11.1M	(5.0M)	(6.0B)	(5.7B)
Property Plant And Equipment Net	277.5K	242.7K	522.8K	2.0M	2.5B	2.7B
Net Debt	(3.9M)	(51.4M)	(34.2M)	(9.1M)	(14.4M)	(15.1M)
Retained Earnings	(71.4M)	(110.1M)	(141.1M)	(171.2M)	(175.3B)	(166.5B)
Accounts Payable	1.0M	2.1M	2.0M	3.4M	1.5M	1.5M
Cash	4.7M	51.7M	34.7M	10.5M	15.7M	19.2M
Non Current Assets Total	566.8K	511.2K	787.6K	3.7M	3.7B	3.8B
Non Currrent Assets Other	289.3K	268.4K	264.8K	1.4M	1.1B	1.2B
Cash And Short Term Investments	4.7M	51.7M	34.7M	10.5M	15.7B	16.5B
Net Receivables	460.2K	1.1M	1.7M	949.2K	230.0K	218.5K
Common Stock Shares Outstanding	2.5M	5.1M	7.0M	7.3M	8.5M	8.9M
Liabilities And Stockholders Equity	7.6M	55.8M	43.8M	21.3M	22.1B	23.2B
Non Current Liabilities Total	1.0M	1M	1.1M	5.8M	6.5B	6.8B
Other Stockholder Equity	70.4M	149.0M	152.5M	166.5M	169.7B	178.2B
Total Liab	8.7M	17.1M	32.7M	26.3M	28.1B	29.5B
Total Current Assets	7.0M	55.3M	43.0M	17.5M	18.4B	19.4B
Short Term Debt	715.0K	270.5K	398.4K	468.7K	549.2M	576.6M
Common Stock	4.2K	8.4K	8.5K	10.0K	870.0	826.5
Current Deferred Revenue	1.6M	10.5M	18.3M	13.7M	16.6M	8.8M
Property Plant And Equipment Gross	37.9K	242.7K	522.8K	2.0M	2.7M	2.9M
Accumulated Other Comprehensive Income	(91.4K)	(155.0K)	(351.3K)	(360.9K)	(428.8M)	(407.4M)
Net Tangible Assets	440.8K	(1.2M)	38.8M	26.3M	23.7M	16.6M
Other Assets	578.0K	447.0K	528.9K	268.4K	308.7K	427.3K
Inventory	(402.7M)	(1.1B)	(1.9B)	(2.5B)	(2.2B)	(2.1B)
Other Current Assets	1.9M	2.5M	6.7M	6.1M	2.5B	2.6B
Property Plant Equipment	9.4K	63.5K	277.5K	242.7K	218.4K	217.9K
Net Invested Capital	(784.4K)	38.8M	11.1M	(5.0M)	(6.0M)	(5.7M)
Net Working Capital	(676.7K)	39.2M	11.4M	(2.9M)	(3.2M)	(3.0M)
Capital Stock	4.2K	8.4K	8.5K	10.0K	870.0	826.5

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

AMT	American Tower Corp
HLTOY	Hellenic Telecommunications Org
NFLX	Netflix

When determining whether Dare Bioscience is a strong investment it is important to analyze Dare Bioscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Dare Bioscience's future performance. For an informed investment choice regarding Dare Stock, refer to the following important reports:

How To Invest In Dare

Details

Is Dare Stock a good investment?

Details

What is Dare Bioscience's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dare Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.

You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dare Bioscience. If investors know Dare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dare Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.48)

Revenue Per Share

0.001

Quarterly Revenue Growth

(0.96)

Return On Assets

(0.68)

Return On Equity

(9.95)

The market value of Dare Bioscience is measured differently than its book value, which is the value of Dare that is recorded on the company's balance sheet. Investors also form their own opinion of Dare Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Dare Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dare Bioscience's market value can be influenced by many factors that don't directly affect Dare Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Dare Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dare Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dare Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dare Non Current Assets Total vs Total Stockholder Equity Analysis

Non Current Assets Total vs Total Stockholder Equity

Non Current Assets Total vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Non Current Assets Total

Total Stockholder Equity

Dare Bioscience fundamental ratios Correlations

Dare Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dare Bioscience fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Long Term Debt Total	+ 1.0	Total Assets
Other Current Liab	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Total Assets
Property Plant And Equipment Net	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Non Currrent Assets Other	+ 1.0	Total Assets

Short Term Debt	- 1.0	Retained Earnings
Total Current Assets	- 1.0	Retained Earnings
Total Liab	- 1.0	Retained Earnings
Other Stockholder Equity	- 1.0	Retained Earnings
Non Current Liabilities Total	- 1.0	Retained Earnings
Cash And Short Term Investments	- 1.0	Retained Earnings